Simultaneous Assessment In Vitro of Transporter and Metabolic Processes in Hepatic Drug Clearance: Use of a Media Loss Approach
Open Access
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 46 (4) , 405-414
Abstract
Hepatocyte drug depletion-time assays are well established for the determination of metabolic clearance in vitro. The present study focuses on the refinement and evaluation of a "media loss" assay, an adaptation of the conventional depletion assay involving centrifugation of hepatocytes prior to sampling, allowing estimation of uptake in addition to metabolism. Using experimental procedures consistent with a high throughput, a selection of 12 compounds with a range of uptake and metabolism characteristics (atorvastatin, cerivastatin, clarithromycin, erythromycin, indinavir, pitavastatin, repaglinide, rosuvastatin, saquinavir and valsartan, together with two control compounds - midazolam and tolbutamide) were investigated in the presence and absence of the cytochrome P450 inhibitor 1-aminobenzotriazole and organic anion transporter protein inhibitor rifamycin SV. Data generated simultaneously for a given drug provided, through the use of a mechanistic cell model, clearance terms characterising metabolism, active and passive uptake, together with intracellular binding and partitioning parameters. Results were largely consistent with the particular drug characteristics, with active uptake, passive diffusion and metabolic clearances ranging between 0.4 - 777, 3 - 383 and 2 - 236 μL/min/mg protein, respectively. The same experiments provided total and unbound drug cellular partition coefficients ranging between 3.8 - 254 and 2.3 - 8.3, respectively and intracellular unbound fractions between 0.014 - 0.263. Following in vitro to in vivo extrapolation, the lowest prediction bias was noted using uptake clearance, compared to metabolic clearance or apparent clearance from the media loss assay alone. This approach allows rapid and comprehensive characterisation of hepatocyte drug disposition valuable for prediction of hepatic processes in vivo.Keywords
This publication has 28 references indexed in Scilit:
- Simultaneous Assessment of Uptake and Metabolism in Rat Hepatocytes: A Comprehensive Mechanistic ModelThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Kinetic Characterization of Rat Hepatic Uptake of 16 Actively Transported DrugsDrug Metabolism and Disposition, 2011
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in Freshly Isolated Rat HepatocytesDrug Metabolism and Disposition, 2008
- Use of Isolated Hepatocyte Preparations for Cytochrome P450 Inhibition Studies: Comparison with Microsomes for Ki DeterminationDrug Metabolism and Disposition, 2007
- Use of Hepatocytes to Assess the Contribution of Hepatic Uptake to Clearance in VivoDrug Metabolism and Disposition, 2007
- Uptake and Intracellular Binding of Lipophilic Amine Drugs by Isolated Rat Hepatocytes and Implications for Prediction of in Vivo Metabolic ClearanceDrug Metabolism and Disposition, 2006
- FUNCTIONAL EXPRESSION OF SINUSOIDAL DRUG TRANSPORTERS IN PRIMARY HUMAN AND RAT HEPATOCYTESDrug Metabolism and Disposition, 2005
- The maintenance of cytochrome P-450 in rat hepatocyte culture: Some applications of liver cell cultures to the study of drug metabolism, toxicity and the induction of the P-450 systemChemico-Biological Interactions, 1990
- HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLSJournal of Cell Biology, 1969